[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-mrc-researching-me-cfs-priority-area-2026":3,"similar-mrc-researching-me-cfs-priority-area-2026":19},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":8,"budget_max_eur":8,"deadline":8,"deadline_note":9,"duration":8,"trl":8,"relevance":8,"why_relevant":8,"early_career":10,"consortium":8,"first_seen":11,"last_updated":8,"update_note":8,"status":12,"stages":13,"call_frequency":14,"next_call_expected":8,"source_url":7,"created_at":15,"updated_at":15,"eligible_countries":16,"description":18,"seo_summary":8},"mrc-researching-me-cfs-priority-area-2026","Researching ME\u002FCFS Priority Area","MRC","https:\u002F\u002Fwww.ukri.org\u002Fopportunity\u002Fresearching-me-cfs-priority-area\u002F",null,"Rolling priority notice — apply through the most relevant MRC grant or fellowship opportunity for your science area and career stage",false,"Sun May 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)","open","Single stage — submit through the relevant existing MRC funding opportunity; contact mecfs@mrc.ukri.org for advice on which scheme to use","Continuous","Sun May 10 2026 05:30:51 GMT+0000 (Coordinated Universal Time)",[17],"GB","Priority notice (active since 2003) encouraging high-quality ME\u002FCFS research applications across any MRC grant or fellowship scheme. Multidisciplinary teams required; patient and public involvement strongly encouraged. Applications in this priority area receive preferential funding consideration when tied on median ranking score. UK research organisations; international co-leads eligible for costs if providing expertise unavailable in the UK.",{"grants":20},[21,24],{"id":22,"name":23,"funder":6,"deadline":8,"budget":8},"mrc-experimental-medicine-stage-one-2026","Experimental medicine stage one",{"id":25,"name":26,"funder":6,"deadline":8,"budget":8},"mrc-experimental-medicine-2026","Experimental Medicine"]